Release Date: 20/05/09 17:54 Summary: Notice of Extraordinary General Meeting/Proxy Form Price Sensitive: No Download Document 1.55MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%